Biohaven (BHVN) Payables (2021 - 2026)

Biohaven (BHVN) has 6 years of Payables data on file, last reported at $10.4 million in Q1 2026.

• For the quarter ending Q1 2026, Payables fell 45.55% year-over-year to $10.4 million; the trailing twelve-month figure through Mar 2026 stood at $10.4 million (down 45.55% YoY), and the FY2025 full-year result was $11.6 million, down 35.42% from the prior year.
• Payables retreated to $10.4 million in Q1 2026, from $11.6 million in the prior quarter.
• In the past five years, Payables ranged from a high of $36.4 million in Q1 2024 to a low of $4.7 million in Q3 2022.
• A 5-year average of $15.8 million and a median of $15.6 million in 2023 frame the typical range for Payables.
• Across the five-year window, Payables surged 151.69% in 2024 and tumbled 47.39% in 2025, its largest moves.
• Tracing BHVN's Payables over 5 years: stood at $10.7 million in 2022, then jumped by 45.54% to $15.6 million in 2023, then increased by 15.74% to $18.0 million in 2024, then sank by 35.42% to $11.6 million in 2025, then slipped by 10.49% to $10.4 million in 2026.
• Business Quant data shows BHVN's Payables at $10.4 million in Q1 2026, $11.6 million in Q4 2025, and $17.5 million in Q3 2025.